Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

This study is testing a minimally invasive treatment for intermediate-risk prostate cancer called focal laser ablation — where a laser is used to destroy only the part of the prostate containing the tumour, guided by a new high-resolution micro-ultrasound system. The aim is to treat the cancer effectively while protecting urinary and sexual function. **You may be eligible if...** - You are a man aged 40–80 - You have intermediate-risk prostate cancer confirmed by biopsy (Gleason score 7 / ISUP Grade 2–3) - Your cancer is limited to one side of the prostate and the tumour is 15 mm or smaller on imaging - Your cancer stage is T1c or T2 - Your PSA level is below 15 ng/mL - You have a life expectancy of more than 10 years **You may NOT be eligible if...** - Your tumour is larger than 15 mm - You have previously had prostate surgery, radiation, hormone therapy, or other treatments like HIFU or cryotherapy for prostate cancer - You are not well enough for focal therapy - You have declined to give informed consent Talk to your doctor to see if this trial is right for you.